| Han, Ying |
NCT05345210: Vonoprazan Hp Dual or Triple Eradication Regimes |
|
|
| Recruiting | 4 | 500 | RoW | Vonoprazan Fumarate+Amoxycillin+Clarithromycin 14days (VAC14), Vonoprazan Fumarate+Amoxycillin 14days (VA14), Vonoprazan Fumarate+Amoxycillin 7days (VA7), Vonoprazan Fumarate+Tetracycline+Furazolidone 14days (VTF14), Vonoprazan Fumarate+Tetracycline+Furazolidone 7days (VTF7) | Xijing Hospital of Digestive Diseases | Helicobacter Pylori | 02/23 | 03/23 | | |
NCT06168214: Standard or Short-course Vonoprazan Non-bismuth Triple Therapy or High-dose Dual Therapy Versus Rabeprazole-bismuth Quadruple Therapy for Primary Helicobacter Pylori Eradication |
|
|
| Recruiting | 4 | 1404 | RoW | Rabeprazloe+bismuth+amoxicillin+clarithromycin, Vonoprazan+amoxicillin+clarithromycin 14 days, Vonoprazan+amoxicillin+clarithromycin 7 days, Vonoprazan+tetracycline+furazolidone 14 days, Vonoprazan+tetracycline+furazolidone 7 days, Vonoprazan+amoxicillin+furazolidone 7 days, Vonoprazan+amoxicillin+tetracycline 14 days, Vonoprazan+amoxicillin 7 days, Vonoprazan+amoxicillin 14 days | Xijing Hospital of Digestive Diseases | the Eradication Rates of Helicobacter Pylori | 11/24 | 12/24 | | |
| Completed | 4 | 108 | US | Moxifloxacin (Topical) | University of California, San Francisco | Antibiotic Resistance, Ocular Surface Microbiome, Gut Resistome | 08/23 | 06/24 | | |
NCT02823353: Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cirrhosis |
|
|
| Completed | 3 | 117 | RoW | Fenofibrate, UDCA | Xijing Hospital of Digestive Diseases | Primary Biliary Cirrhosis | 05/22 | 06/22 | | |
NCT02823366: Fenofibrate for Patients With Primary Biliary Cirrhosis Who Had An Inadequate Response to Ursodeoxycholic Acid |
|
|
| Recruiting | 3 | 104 | RoW | Fenofibrate, UDCA | Xijing Hospital of Digestive Diseases | Primary Biliary Cirrhosis | 12/23 | 12/23 | | |
SHINY, NCT06157502: Shuxuening Injection in the Treatment With Intravenous Thrombolysis in Patients With Ischemic Stroke |
|
|
| Recruiting | 3 | 1380 | RoW | Shuxuening Injection, Placebo | Beijing Tiantan Hospital | Ischemic Stroke, Acute | 06/25 | 12/26 | | |
TAPIS, NCT06316570: Ticagrelor With Aspirin Dual Antiplatelet Therapy Combined With Intravenous Thrombolysis for Ischemic Stroke |
|
|
| Recruiting | 3 | 1380 | RoW | Early Dual Antiplatelet Therapy, Ticagrelor and Aspirin, Placebo, Placebo of Ticagrelor and Aspirin | Beijing Tiantan Hospital | Ischemic Stroke, Acute | 12/25 | 12/26 | | |
NCT05751967: Fenofibrate Combined with Ursodeoxycholic Acid in Subjects with Primary Biliary Cholangitis |
|
|
| Recruiting | 3 | 150 | RoW | Placebo Combined With Ursodeoxycholic Acid, UDCA 13-15mg/kg/d, Fenofibrate Combined With Ursodeoxycholic Acid | Xijing Hospital of Digestive Diseases | Primary Biliary Cholangitis | 12/25 | 12/25 | | |
| Recruiting | 3 | 640 | Europe, Canada, US | Low Energy SLT, Standard Energy SLT | West Virginia University, University of Pittsburgh | Glaucoma and Ocular Hypertension | 06/27 | 08/27 | | |
NCT06365424: Fenofibrate in Patients with Primary Biliary Cholangitis (PBC) |
|
|
| Recruiting | 2/3 | 117 | RoW | Fenofibrate, UDCA | Xijing Hospital of Digestive Diseases | Primary Biliary Cholangitis | 04/27 | 04/27 | | |
NCT06174402: Fenofibrate in Combination with Ursodeoxycholic Acid in Primary Biliary Cholangitis |
|
|
| Recruiting | 2/3 | 184 | RoW | Fenofibrate, Placebo, UDCA | Han Ying | Primary Biliary Cholangitis | 12/25 | 12/25 | | |
NCT05749822: Fenofibrate for Compensated Cirrhosis Patients with Primary Biliary Cholangitis |
|
|
| Recruiting | 2/3 | 104 | RoW | Fenofibrate 200mg, Placebo, UDCA | Xijing Hospital of Digestive Diseases | Primary Biliary Cholangitis | 12/25 | 12/25 | | |
NCT03370744: Prediction of Cognitive Decline by Neuroimaging Techniques and the Application in Diagnosis and Treatment of Preclinical AD |
|
|
| Completed | N/A | 300 | RoW | Neuropsychological scale | XuanwuH 2 | Subjective Cognitive Decline, Preclinical Alzheimer's Disease | 06/20 | 12/22 | | |
Pan-CHESS1801, NCT03778775: Transient Elastography (FibroTouch) for Assessing Risk of Gastroesophageal Varices Bleeding in Compensated Cirrhosis |
|
|
| Recruiting | N/A | 200 | Japan, RoW | Liver sitffness measurement, Esophagogastroduodenoscopy | Nanfang Hospital of Southern Medical University, Beijing Tsinghua Changgeng Hospital, LanZhou University, Beijing 302 Hospital, Xijing Hospital of Digestive Diseases, Wuhan Union Hospital, China, Zhujiang Hospital, Second Affiliated Hospital of Xi'an Jiaotong University, The Central Hospital of Lishui City, Xingtai People's Hospital, Seventh Medical Center of PLA Army General Hospital, Shandong Provincial Hospital, Shunde Hospital, Southern Medical University, Medistra Hospital, University of Indonesia, Ankara University, Osaka City University, Chulalongkorn University | Compensated Liver Cirrhosis, Gastroesophageal Varices Bleeding | 06/21 | 03/22 | | |
NCT05273385: Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma |
|
|
| Recruiting | N/A | 40 | US | Nanodropper | University of California, San Francisco, Nanodropper, Inc., Icare Finland Oy | Glaucoma, Ocular Hypertension, Open Angle Glaucoma | 12/24 | 12/24 | | |
| Recruiting | N/A | 800 | RoW | Multiple features extraction | XuanwuH 2, University of Cologne | Alzheimer Disease, Subjective Cognitive Decline, Neuroimaging, Gene | 12/24 | 12/25 | | |
NCT05606237: Efficacy of Repeated Low-level Red-light Therapy in Myopia Control |
|
|
| Recruiting | N/A | 90 | US | Low-level Red Light Therapy Device | University of California, San Francisco, University of Melbourne | Myopia | 07/25 | 07/25 | | |
| Recruiting | N/A | 226 | Canada, US | Sulcus tube placement, Anterior chamber (AC) tube placement | University of Pennsylvania, National Eye Institute (NEI), University of California, San Francisco, Stanford University | Glaucoma | 12/26 | 12/27 | | |
NCT05297006: Regulation and Mechanism of New Compound Functional Ingredients in Infants |
|
|
| Not yet recruiting | N/A | 180 | RoW | The infants who drank milk powder were given a dietary intervention four months before | Peking University Third Hospital, Peking University First Hospital, Peking University People's Hospital | Sialic Acid, Oligosaccharide | 10/22 | 12/22 | | |
